Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AURN001 in corneal edema secondary to corneal endothelial dysfunction
NCT06041256Phase 2Completed
- Sponsor
- Aurion Biotech
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules, Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of AURN001 in corneal edema, sponsored by Aurion Biotech. Started Oct 2023; status: completed.
02
Drugs
AURN001
03
Conditions
corneal edema
Beyond the preview
Go deeper on NCT06041256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06041256.